Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Mostrar otras versiones (1)

A novel coronavirus SARS-CoV-2, also called novel coronavirus 2019 (nCoV-19), started to circulate among humans around December 2019, and it is now widespread as a global pandemic. The disease caused by SARS-CoV-2 virus is called COVID-19, which is highly contagious and has an overall mortality rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chunlong, Sacco, Michael D., Hurst, Brett, Townsend, Julia A., Hu, Yanmei, Szeto, Tommy, Zhang, Xiujun, Tarbet, Bart, Marty, Michael T., Chen, Yu, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263507/
https://www.ncbi.nlm.nih.gov/pubmed/32511378
http://dx.doi.org/10.1101/2020.04.20.051581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263507/
https://www.ncbi.nlm.nih.gov/pubmed/32511378
http://dx.doi.org/10.1101/2020.04.20.051581

Ejemplares similares